The study aimed to reduce traces of HIV in the body and help the immune system fight the virus without chronic medication.

The trial conducted in Durban, South Africa, showed that 20 per cent of participants remain off ART and are virally suppressed after one-and-a-half years, according to a press statement from the ...

Groundbreaking South African HIV cure trial shows 20% of participants maintaining viral suppression without medication for 18 ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

A pioneering study at UKZN has demonstrated that 20% of HIV patients in the trial remained off antiretroviral therapy while ...

Groundbreaking HIV cure study in South Africa shows the safety and potential efficacy of a novel therapeutic regimen in women ...

The results of a groundbreaking trial carried out in Durban to find a cure for HIV are showing promise, scientists say.

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...